The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women
Official Title: Effects of Soy on Estrogens in Breast Fluid and Urine
Study ID: NCT00513916
Brief Summary: RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. Eating a diet high in isoflavones, compounds found in soy foods, may keep cancer from forming. PURPOSE: This randomized phase III trial is studying the effects of dietary soy on estrogens in breast fluid, blood, and urine samples from healthy women.
Detailed Description: OBJECTIVES: * Examine the effects of two daily servings of soy on estrogen levels in nipple aspirate fluid (NAF) and serum. * Investigate cytologic patterns of epithelial breast cells obtained from NAF as a measure of proliferation in relation to soy intake. * Explore the effect of two daily servings of soy on cytochrome alterations of estrogen metabolism as expressed in the formation of urinary 2-, 16α-, and 4-hydroxy estrogen metabolites. * Compare estrogen levels in NAF and serum measured at the same time during the luteal phase. OUTLINE: This is a multicenter study. Participants are randomized to 1 of 2 intervention arms. * Arm I: Participants partake in a high soy diet consisting of 2 daily soy servings (approximately 50mg isoflavones). The choice of soy foods will include ½ cup of tofu, ¾ cup of soy milk, or ¼ cup of soy nuts. Replacement of currently consumed foods with soy foods will be encouraged. * Arm II: Participants will be asked to keep their soy intake below 3 servings per week. The participants will also receive general nutrition counseling. In both arms, intervention continues for 6 months. After 6 months, participants undergo a 1-month washout period and then cross-over to the other intervention arm. Nipple aspirate fluid, urine, and blood samples are collected periodically to measure laboratory endpoints.
Minimum Age: 30 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Cancer Research Center of Hawaii, Honolulu, Hawaii, United States
Name: Gertraud Maskarinec, MD, PhD
Affiliation: University of Hawaii Cancer Research Center
Role: STUDY_CHAIR